Optimi Health

Optimi Health Book Value per Share

The Book Value per Share of Optimi Health (OPTI.CN) as of Oct 27, 2026 is 0.07 CAD. In the previous year, Book Value per Share was 0.10 CAD — a change of -31.38% (lower).

Book Value per Share

0.07CAD

YoY

-31.38%

Last updated:

Book Value per Share of Optimi Health is 2025 0.07 CAD. Book Value per Share of Optimi Health was 2024 0.10 CAD. It decreases by -31.38% lower compared to the previous year.

The Optimi Health Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2020
0.05 CAD
Jan 1, 2021
0.22 CAD
Jan 1, 2022
0.17 CAD
Jan 1, 2023
0.14 CAD
Jan 1, 2024
0.10 CAD
Jan 1, 2025
0.07 CAD
The Optimi Health Book Value per Share history
YEARBook Value per ShareYoY
0.07CAD-31.38%
0.10CAD-27.52%
0.14CAD-17.54%
0.17CAD-23.96%
0.22CAD+298.44%
0.05CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Optimi Health Stock analysis

What does Optimi Health do? Optimi Health Corp develops, cultivates, extracts, processes, and distributes functional mushrooms and psychedelic substances. The company produces licensed drug and nutraceutical products including natural and synthetically formulated GMP-grade psilocybin, psilocin, MDMA, and other psychedelic substances under Health Canada regulations. Optimi supplies health food distributors, drug developers, and patients through its manufacturing facilities. The firm operates as a supplier of drug and nutraceutical products serving domestic and international health and wellness markets. Optimi Health Corp owns approximately 20,000 technologically advanced manufacturing, cultivation, and analytical facilities. These facilities support the production of functional mushrooms and psychedelic substances for health food distributors, drug developers, and patients. The company focuses on supplying synthetic and natural psychedelics to the international market while adhering to Health Canada's drug manufacturing and formulation standards. The firm's product portfolio includes GMP-grade psilocybin, psilocin, MDMA, and functional mushrooms, targeting health food distributors, drug developers, and patients. Optimi operates as a supplier of drug and nutraceutical products, serving both domestic and international health and wellness markets. Its manufacturing capabilities enable the production of natural and synthetically formulated psychedelic substances under Health Canada's regulatory framework. Optimi Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optimi Health stock

Book Value per Share of Optimi Health is 0.07 CAD in 2025.

Book Value per Share of Optimi Health changed from 0.10 CAD to 0.07 CAD, representing a -31.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Optimi Health since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Optimi Health

All Key Metrics — Optimi Health